FDA Requires Lower Dosing of Zolpidem
January 21, 2013 (Issue: 1408)
On January 10, 2013, the FDA issued a news release
to announce that it was requiring the manufacturers of
the zolpidem-containing products Ambien, Ambien
CR, Edluar and Zolpimist, which are all approved for
treatment of insomnia, to lower the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this issue? Gain access below.